文献速递头颈外科

HPV时代下经口机器人手术治疗口咽鳞状细胞癌

Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
PubMed 文献 · Head Neck · 2017-12-15

该研究基于美国国家癌症数据库,纳入1873例已知HPV状态的口咽鳞状细胞癌患者,比较主要经口机器人手术(TORS)与主要放疗的生存差异。

要点

  • HPV阳性口咽癌患者中,TORS与放疗的3年生存率无显著差异。
  • 治疗策略选择应结合HPV状态个体化评估。

核心结论

  • 基于TORS的治疗策略在HPV阴性口咽鳞状细胞癌患者中与更优生存相关,但在HPV阳性患者中未观察到类似差异。

研究设计与样本

  • 查询美国国家癌症数据库,纳入已知HPV状态并接受主要TORS或主要放疗的口咽鳞状细胞癌患者,共1873例,采用倾向匹配控制混杂因素。

主要发现

  • 1873例患者中73%为HPV阳性,30%接受TORS治疗。

临床怎么用

  • 对于HPV阴性口咽鳞状细胞癌患者,可考虑优先选择基于TORS的手术策略以改善生存。
  • 对于HPV阳性患者,TORS与放疗的生存结局相似,治疗选择应综合功能保留和患者偏好个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The emergence of transoral robotic surgery (TORS) ignited the debate between surgical and nonsurgical strategies on oropharyngeal squamous cell carcinoma (SCC) management; a question further complicated by human papillomavirus (HPV). We evaluated the survival by treatment strategy independently in HPV-related and HPV-nonrelated oropharyngeal SCC. METHODS: The National Cancer Database was queried for patients with oropharyngeal SCC with known HPV status who underwent primary TORS or primary radiotherapy. The overall survival (OS) was compared by treatment strategy, including propensity matching to control for confounders. RESULTS: Of 1873 patients, 73% were HPV-positive and 30% were treated with TORS. The propensity-matched patients with HPV-positive disease displayed no significant difference in 3-year survival; 95% versus 91% (P = .116) for the TORS versus primary radiotherapy. In the HPV-negative cohort, TORS was associated with superior survival; 84% versus 66% (P = .01). CONCLUSION: The TORS-based approach was associated with superior survival in patients with HPV-negative oropharyngeal SCC; similar difference was not observed in patients with HPV-positive disease.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mahmoud O, Sung K, Civantos FJ, et al. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus. Head Neck. 2017. PMID: 29244238. doi:10.1002/hed.25036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。